Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced the closing of the divestment of Shiel Medical Laboratory, Inc. to Quest Diagnostics, Inc. as of December 7, 2017.
Fresenius Medical Care North America (FMCNA) employees put on their walking shoes and raised nearly $300,000, the most amount ever raised by a National Team participating in Kidney Walk, the centerpiece fundraiser of the National Kidney Foundation (NKF).
Fresenius Medical Care North America (FMCNA), the country’s leading provider of kidney care products and services, announced today the first performance year results from its End Stage Renal Disease Seamless Care Organizations (ESCOs).
Fresenius Medical Care Showcases Global Research Leadership at World’s Largest Gathering of Kidney Professionals
Fresenius Researchers and Clinical Experts from across the Globe Present More Than 75 Abstracts at the American Society of Nephrology’s 2017 Kidney Week Symposium, Demonstrating Commitment to Innovating Healthcare through Science
At today’s Special Meeting, the stockholders of NxStage Medical, Inc. approved the adoption of the previously announced merger agreement with Fresenius Medical Care, with approximately 72% of outstanding shares having voted in favor of the transaction.
Our Kingsport, Tennessee clinic welcomed Rep. Phil Roe, M.D. (R-Tenn.), on October 9 to tour the facility, meet and observe patients undergoing dialysis treatment and discuss innovative treatments with clinic staff.
Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced the divestment of the business of Shiel Medical Laboratory, Inc. to Quest Diagnostics, Inc. Shiel provides comprehensive non-dialysis laboratory services in the New York-New Jersey metropolitan area.
Fresenius Medical Care North America Announces Scholarship Program for Nurses of the American Nephrology Nurses Association
To recognize nephrology nurses’ passion and dedication to caring for patients with kidney disease, Fresenius Medical Care North America (FMCNA) today announced it is providing the American Nephrology Nurses Association (ANNA) a $20,000 grant for educational scholarships.
Nephrology Nurses Week Highlights Shared Passion of Mother and Daughter Dedicated to Caring for Fresenius Kidney Care Dialysis Patients
Nephrology nurse Katrina Tamayo Guzman, RN, shares many interests with her mom, Delia, RN, BSN, a clinical manager at Fresenius Kidney Care in Elmhurst, Ill. Most striking is their dedication to caring for people living with kidney disease who require dialysis to stay alive.
Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen its Vertically Integrated Dialysis Business
NxStage, which just like Fresenius Medical Care North America, has its headquarters in the Boston, Massachusetts area, was founded in 1998 and has approximately 3,400 employees. It develops, produces and markets an innovative product portfolio of medical devices for use in home dialysis and in the critical care setting.
Frenova Renal Research Announces Expansion of F1RST Up™ (Frenova Rapid STart Up) Alliance of Investigative Sites Designed to Speed Clinical Trial Initiation
Frenova Renal Research, the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research, today announced that its F1RST Up™ alliance of clinical research sites focusing on kidney disease has expanded to include 55 physician investigators representing 23 sites.
Fresenius Medical Care North America Announces Kidney Walk National Team in Support of the National Kidney Foundation
Fresenius Medical Care North America (FMCNA), the nation’s leading renal care company, announces a company-wide national team in support of the National Kidney Foundation’s (NKF) annual Kidney Walk, the nation's largest fundraiser to fight kidney disease.